Survival from rare bone cancer remains low

Ten-year survival of a rare malignancy called mesenchymal chondrosarcoma has been reported to be as low as 20 percent. But a new study has found survival is not as dismal as prior reports. More than half (51 percent) of patients survived at least five years, and 43 percent survived at least 10 years.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1Ph3oT6